Is Next Generation Sequencing the future of blood group testing?

scientific article published on 07 March 2014

Is Next Generation Sequencing the future of blood group testing? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.TRANSCI.2014.02.013
P698PubMed publication ID24667159

P2093author name stringLouise Tilley
Shane Grimsley
P2860cites workA tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencersQ21266698
Blood group genotyping: from patient to high-throughput donor screeningQ33472914
SMIM1 underlies the Vel blood group and influences red blood cell traitsQ34263872
Matrix-assisted laser desorption/ionisation, time-of-flight mass spectrometry-based blood group genotyping--the alternative approachQ34503169
Rapid, scalable and highly automated HLA genotyping using next-generation sequencing: a transition from research to diagnosticsQ34655295
Next generation diagnostics in inherited arrhythmia syndromes : a comparison of two approaches.Q36537110
Disruption of SMIM1 causes the Vel- blood type.Q36870116
Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities.Q37435858
A new blood group antigen is defined by anti-CD59, detected in a CD59-deficient patientQ37652769
Developing genome and exome sequencing for candidate gene identification in inherited disorders: an integrated technical and bioinformatics approachQ38024423
Challenges of alloimmunization in patients with haemoglobinopathiesQ38049189
Next-generation sequencing in the clinic: promises and challengesQ38061737
16(th) IHIW : review of HLA typing by NGS.Q38072775
Prospects for the provision of genotyped blood for transfusion.Q38124402
International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Cancun report (2012).Q42603051
Homozygosity for a null allele of SMIM1 defines the Vel-negative blood group phenotype.Q43686788
International reference reagents to standardise blood group genotyping: evaluation of candidate preparations in an international collaborative studyQ46046965
High-throughput red blood cell antigen genotyping using a nanofluidic real-time polymerase chain reaction platformQ46673377
High-throughput multiplex PCR genotyping for 35 red blood cell antigens in blood donors.Q50522382
A new blood group system, RHAG: three antigens resulting from amino acid substitutions in the Rh-associated glycoprotein.Q50583516
Set-up and routine use of a database of 10,555 genotyped blood donors to facilitate the screening of compatible blood components for alloimmunized patients.Q50606904
P433issue2
P304page(s)183-188
P577publication date2014-03-07
P1433published inTransfusion and Apheresis ScienceQ15758507
P1476titleIs Next Generation Sequencing the future of blood group testing?
P478volume50

Reverse relations

cites work (P2860)
Q39622058A D+ blood donor with a novel RHD*D-CE(5-6)-D gene variant exhibits the low-frequency antigen RH23 (D(W) ) characteristic of the partial DVa phenotype
Q36305936A preliminary evaluation of next-generation sequencing as a screening tool for targeted genotyping of erythrocyte and platelet antigens in blood donors.
Q36024810ABO allele-level frequency estimation based on population-scale genotyping by next generation sequencing.
Q57795869Complete next-generation sequencing: establishment of reference alleles
Q41031823Duffy blood group phenotype-genotype correlations using high-resolution melting analysis PCR and microarray reveal complex cases including a new null FY*A allele: the role for sequencing in genotyping algorithms.
Q96603209Genomic analyses of KEL alleles in alloimmunized thalassemia patients from Iran
Q39149426Genotyping Applications for Transplantation and Transfusion Management: The Emory Experience
Q36423045Insights into RHCE Molecular Analysis in Samples with Partial D Variants: the Experience of Western France
Q37417326Molecular immunohaematology round table discussions at the AABB Annual Meeting, Anaheim 2015
Q51412052Molecular immunohaematology round table discussions at the AABB Annual Meeting, Orlando 2016.
Q35227620Next-generation sequencing is a credible strategy for blood group genotyping
Q39309164Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype
Q38767551The etiology of congenital nephrotic syndrome: current status and challenges
Q55234148Transfusion Medicine and Molecular Genetic Methods.

Search more.